Fred Hutchinson Cancer Center is an independent, nonprofit organization providing adult cancer treatment and groundbreaking research focused on cancer and infectious diseases. Based in Seattle, Fred Hutch is the only National Cancer Institute-designated cancer center in Washington.
With a track record of global leadership in bone marrow transplantation, HIV/AIDS prevention, immunotherapy and COVID-19 vaccines, Fred Hutch has earned a reputation as one of the world's leading cancer, infectious disease and biomedical research centers. Fred Hutch operates eight clinical care sites that provide medical oncology, infusion, radiation, proton therapy and related services, and network affiliations with hospitals in five states. Together, our fully integrated research and clinical care teams seek to discover new cures to the world's deadliest diseases and make life beyond cancer a reality.
At Fred Hutch we value collaboration, compassion, determination, excellence, innovation, integrity and respect. These values are grounded in and expressed through the principles of diversity, equity and inclusion. Our mission is directly tied to the humanity, dignity and inherent value of each employee, patient, community member and supporter. Our commitment to learning across our differences and similarities make us stronger. We seek employees who bring different and innovative ways of seeing the world and solving problems. Fred Hutch is in pursuit of becoming an anti-racist organization. We are committed to ensuring that all candidates hired share our commitment to diversity, anti-racism and inclusion.
The Post-Doctoral Research Fellow (full-time, 6 month duration) will work on three projects with various faculty members in the Infectious Disease Sciences Program related to post-CAR T cell immunity with, specifically looking at how a novel T-SPOT assay predicts major infections post treatment. The second project will look to assess late CMV immunity in patients completing letermovir prophylaxis, and final research project will evaluate infections post-hematopoietic cell transplantation and compare results to those reported to NMDP.
MINIMUM QUALIFICATIONS:
PREFERRED QUALIFICATIONS:
A statement describing your commitment and contributions toward greater diversity, equity, inclusion, and antiracism in your career or that will be made through your work at Fred Hutch is requested of all finalists.
The annual base salary range for this position is from $77,976 to $150,000 and pay offered will be based on experience and qualifications. Fred Hutchinson Cancer Center offers employees access to a retirement savings plan, an employee assistance program, paid sick leave (1 hour for every 30 hours worked), and prorated paid holidays (up to 11 days per year).
...looking for a rewarding career that lets you share your love for travel while helping others create unforgettable experiences? Miracle... ...its team, and were looking for enthusiastic Remote Travel Consultants to join us! Why Join Us? At Miracle Getaways by...
...live-streamed events across various platforms (web, mobile, and TV). We are seeking a talentedWeb & Marketing Designerto work with our creative team and help drive enhanced... ...internal teams to understand objectives and develop design concepts for various initiatives such as...
...Physical Therapist Key information: Title: Physical Therapist Location/work environment: In facility Reporting structure... ...patient needs, develop their recovery plans, and deliver physical therapy. You're a healer and a helper, which is why you got into...
DescriptionPosition at ACCESS San Fernando ValleyACCESS San Fernando Valley is seeking an experienced Veterinary Hospital Administrator to join our team!Pay Range: $115k - $125K/yearACCESSSan Fernando Valley invests heavily in our teams growth and development...
...Overview Fred Hutchinson Cancer Center is an independent, nonprofit organization providing adult cancer treatment and groundbreaking research focused on cancer and infectious diseases. Based in Seattle, Fred Hutch is the only National Cancer Institute-designated cancer...